News

Healthcare, Life Sciences

All news
Clean Cells acquiert Xegen et intègre la bio-informatique à son offre de séquençage
16/09/2026
Mergers & Acquisitions

Clean Cells acquires Xegen and integrates bioinformatics into its sequencing offering

Clean Cells, a Montaigu-Vendée-based company specialising in quality control for biopharmaceutical products and a subsidiary of the Clean Biologics group, has announced the acquisition of Xegen. Based in Gémenos, in the Bouches-du-Rhône, Xegen specialises in the analysis and interpretation of next-generation sequencing data. The transaction supports Clean Cells’ launch of a sequencing-based viral safety testing […]
Astorg finalise l'acquisition de l'activité microbiologie de Thermo Fisher Scientific
28/08/2026
Mergers & Acquisitions

Astorg closes the acquisition of Thermo Fisher Scientific’s microbiology business

Astorg, a pan-European private equity firm specialised in healthcare and life sciences, has announced the closing of the acquisition of Thermo Fisher Scientific‘s microbiology business. The entity becomes a standalone company, led by Dirk Bontridder as CEO, and will operate under a new brand from the end of 2026. Analysis by the experts at Auris […]
Eurofins Scientific renforce sa présence en Amérique du Nord
31/07/2026
Mergers & Acquisitions

Eurofins Scientific strengthens its footprint in North America

Eurofins Scientific has announced that it has entered into an agreement with Element Materials Technology to acquire its life sciences testing services business in North America, for an enterprise value of 400 million dollars. The deal strengthens the group’s network in key US and Canadian regions where it was historically under-represented. Analysis by the experts […]
Cyllene Therapeutics : levée de fonds de 33 M€ en biotech
17/07/2026
Mergers & Acquisitions

Cyllene Therapeutics raises 33 million euros and rebrands to accelerate its EG110A drug candidate

Paris-based biotech Cyllene Therapeutics, formerly known as EG 427, has just closed a 33 million euro Series C. The deal, announced on 7 July 2026, comes with a change of name that marks the company’s shift into a more advanced clinical stage. Analysis by the experts at Auris Finance, advisors in mergers, acquisitions and financial […]
Semble lève 35 millions d'euros et accélère son déploiement en France
08/07/2026
Funding & Fundraising

Semble raises 35 million euros to accelerate its rollout in France

Semble, a UK-based clinical software platform, has announced a 35 million euro round led by Revaia and Partech. With more than 10 million patients already supported across Europe, the company will use the fresh capital to establish itself as the leading connected health infrastructure in the French market, one of the most demanding and heavily […]
Bionyra Pharma lève 143 millions d'euros pour ses biothérapies contre les maladies inflammatoires sévères
07/07/2026
Mergers & Acquisitions

Bionyra Pharma raises 143 million euros for its biotherapies against severe inflammatory diseases

Bionyra Pharma, a Paris-based biotech founded in 2025, formally announced on 22 June 2026 a 143 million euro fundraising, described as the largest ever completed by a French biotech. The proceeds will finance the clinical development of three molecules for the treatment of severe atopic dermatitis and chronic inflammatory bowel diseases. Analysis by the experts […]
See More